ATH alterity therapeutics limited

ATH Chart Thread, page-73

  1. 658 Posts.
    lightbulb Created with Sketch. 6035

    Hi Pivalde


    You raise some interesting points.


    I suspect that the reason for Claassen making the presentation is both clever and strategic.


    Claassen is probably one of the most respected professors of neurology in the world.


    He will not be seen as a ‘company man’ pushing a product (so arm’s length). He is a world expert, explaining a study in which he had critical input. A very, very successful study. Ground breaking.


    With Claassen doing the presentation, the presentation will gain further weight and, to some degree credibility. Stamler is an outstanding researcher, but his profile in the neurology world is nowhere near that of Claassen.


    This presentation should now draw its maximum audience and I would dearly love to be there, and to hear the questions from the floor.

    A very, very smart move. I have seen it done in other ‘similar’ situations, in conferences around the world.

    All my opinion, as always.

    Last edited by Outlander2: 08/04/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.1¢
Change
0.000(0.00%)
Mkt cap ! $100.4M
Open High Low Value Volume
1.0¢ 1.1¢ 1.0¢ $45.25K 4.114M

Buyers (Bids)

No. Vol. Price($)
31 11296464 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 7952306 5
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.